Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -13.13
- Piotroski Score 3.00
- Grade Buy
- Symbol (NH)
- Company NantHealth, Inc.
- Price $1.35
- Changes Percentage (0%)
- Change -$0
- Day Low $1.35
- Day High $2.39
- Year High $2.39
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/02/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$11.40
- Trailing P/E Ratio -0.12
- Forward P/E Ratio -0.12
- P/E Growth -0.12
- Net Income $-67,779,000
Income Statement
Quarterly
Annual
Latest News of NH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Tottenham's Dominic Solanke to train ahead of Bournemouth trip but 'still not 100 per cent'
Dominic Solanke will train before Tottenham's game against Bournemouth, but Ange Postecoglou mentions he's not fully recovered. Cristian Romero remains out with a foot injury. Spurs are gradually rega...
By The New York Times | 8 hours ago -
Two months into the NHL season, what's real and what's not?
The NHL season is a rollercoaster with surprises like the Columbus Blue Jackets climbing in the standings, driven by their young talent. Other notable trends include the struggles of teams like the Ne...
By The New York Times | 9 hours ago -
Inside Haoxi Simon Wang's journey to the top of the 2025 NHL Draft from China
Haoxi Simon Wang, a 6-foot-5.5 defenseman from China, is making waves in the hockey world, set to become the highest-drafted Chinese-born player in NHL history....
By The New York Times | 9 hours ago
